Objectives This study is designed to examine the immediate and short-term outcomes of patients who have undergone slow pathway ablation/modification for atrioventricular nodal reentrant tachycardia.
Introduction
Atrioventricular nodal reentrant tachycardia is among the most common forms of paroxysmal supraventricular tachycardia. Radiofrequency ablation of either the 'fast' or 'slow' components of the atrioventricular node was introduced in the early 1990s [1] [2] [3] [4] [5] [6] [7] [8] . The technique of fast pathway ablation has been largely abandoned due to the relatively high incidence of complete atrioventricular block associated with this technique [4, 5, 7, 9, [10] [11] [12] . The slow pathway can be targeted at the inferoposterior region of the triangle of Koch, a significant distance from the atrioventricular node, and is therefore associated with a significantly lower incidence of complete atrioventricular block. The combined results from several centres have established the superiority of this approach [13] [14] [15] and slow pathway ablation has therefore become the treatment of choice for atrioventricular nodal reentrant tachycardia.
Except in rare cases, atrioventricular nodal reentrant tachycardia is associated with 'dual atrioventricular nodal physiology', evidenced by the presence of an AH jump of at least 50 ms and one or more atrial reentrant beats (echo beats) during programmed atrial stimulation. The onset of tachycardia is frequently associated with one of these phenomena. The slow pathway is said to have been 'ablated' if there is no evidence of dual physiology at the end of the procedure. The slow pathway is said to have been 'modified' if dual physiology is preserved but it is no longer possible to induce tachycardia (even following the administration of isoprenaline) following the delivery of radiofrequency energy in the slow pathway region. It has been suggested that slow pathway modification is superior to slow pathway ablation in the treatment of atrioventricular nodal reentrant tachycardia as the former is associated with less damage to the atrioventricular node and therefore the incidence of late atrioventricular block is likely to be lower. There is, however, no evidence for this and, although there are a number of reports describing the initial results of slow pathway ablation for atrioventricular nodal reentrant tachycardia, there are few accounts in the literature of the long-term follow-up of these patients. In this study we report the initial and long-term follow-up of 379 consecutive patients who underwent slow pathway ablation or modification for atrioventricular nodal reentrant tachycardia in a single centre.
Patients and methods

Patient selection
Prior to radiofrequency ablation all patients underwent diagnostic electrophysiological testing. Standard criteria were used to diagnose atrioventricular nodal reentrant tachycardia and to discriminate it from other causes of supraventricular tachycardia [4] . The arrhythmia was non-inducible in a small proportion of patients referred for ablation. In these cases, the slow pathway was only targeted when a reliable diagnostic electrophysiological study had been performed in another centre. Rarely, ablation was performed in patients with narrow complex tachycardia documented on a 12-lead electrocardiograph with characteristics consistent with a diagnosis of atrioventricular nodal reentrant tachycardia in whom dual atrioventricular node physiology was clearly seen.
Technique of targeting the slow pathway
All patients gave informed consent and were warned of the potential risks of atrioventricular block necessitating permanent pacemaker implantation. A diagnostic electrophysiological study was then performed. During this, the presence of an A-H jump and/or atrioventricular nodal reentrant (echo) beats were ascertained (implying the presence of dual atrioventricular node physiology) and atrioventricular nodal reentrant tachycardia was induced on at least one occasion, usually by programmed atrial or ventricular extrastimulation. The patient then received 5000 IU of intravenous heparin and an ablation catheter was advanced into the right atrium. The catheter was advanced across the tricuspid annulus and then withdrawn to the His position. Following this, the catheter was manoeuvred to the posterior aspect of the tricuspid septal annulus. The bipolar mapping electrogram was examined and radiofrequency energy was delivered when an atrioventricular amplitude ratio of 0·1 to 0·5 was observed. If two pulses in this region proved unsuccessful, the catheter was positioned in a more midseptal or even anteroseptal position, maintaining an atrioventricular ratio in the 0·1-0·5 range. The power output of the radiofrequency generator was adjusted automatically according to a preselected catheter tip temperature which varied between 60 and 70 degrees Celsius. Energy was delivered for 60 s unless the catheter displaced or the temperature was inadequate. The practice of applying 'safety burns' was not employed. This technique has been termed the 'stepwise approach' and is described in detail elsewhere [16] . The 'gold standard' end-point for success was non-inducibility of initially inducible atrioventricular nodal reentrant tachycardia, even following administration of isoprenaline. The presence of rapid junctional beats during energy delivery was also taken as an important indicator of success. The slow pathway was said to be 'modified' (as opposed to 'ablated') when atrioventricular nodal reentrant tachycardia was no longer inducible but an A-H jump of at least 50 ms (usually accompanied by one or two atrial echo blasts) was present at the end of the procedure. This implies that the slow pathway had been modified so that atrioventricular nodal reentrant tachycardia was no longer inducible but that dual atrioventricular node physiology was maintained.
Study population
From January 1994 to April 1997 inclusive, 379 consecutive patients underwent slow pathway ablation/ modification on an intention-to-treat basis. Patient characteristics are summarized in Table 1 and procedural details are summarized in Table 2 . One hundred and twenty-four patients were male. The mean age was 47·1 years (range 16-82, SD 14·7). The majority of patients had failed pharmocological therapy with at least one drug either because of lack of efficacy or unacceptable side-effects. Antiarrhythmic therapy is shown in Table 3 . All patients underwent transthoracic echocardiography before and after the procedure.
Follow-up
The procedures were performed in a tertiary referral centre. Accordingly, most patients were seen by their 
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referring cardiologist and not in our centre. However, a questionnaire was sent to all patients. Patients were asked if they had experienced a recurrence of symptoms and, if so, they were asked to describe these symptoms. Details of antiarrhythmic drug therapy were ascertained and, finally, patients were asked if they felt that the procedure had been a success. In cases in which the patient had reported recurrent arrythmias and these had not been treated in this unit, the patient's cardiologist was contacted and the details obtained. Follow-up by questionnaire was obtained in 354 (96%) patients at a mean of 20·6 (SD 6·3) months after the procedure.
Statistical analysis
Continuous variables are expressed as mean SD. Characteristics of patients experiencing initial failure and recurrence of tachycardia are shown in Table 4 . Multivariate stepwise logistic regression was performed to find the most powerful independent predictors of initial failure and recurrence of tachycardia at follow-up. A P value of less than 0·05 was regarded as significant.
Results
Procedural success was defined as failure to induce atrioventricular nodal reentrant tachycardia despite exhaustive attempts including administration of sufficient isoprenaline to raise the heart rate above 120 beats . min 1 . Of the 379 patients who were referred for slow pathway modification/ablation there were 10 cases of primary failure and two additional cases of atrioventricular block, giving an overall initial success rate of 96·8%. Fast pathway ablation was performed in these 10 patients. This was successful in all cases but resulted in atrioventricular block in one case. There were a total of six cases of 'atypical atrioventricular nodal reentrant tachycardia' consisting of 'slow-slow' atrioventricular nodal reentrant tachycardia in three cases and 'fast-slow' atrioventricular nodal reentrant tachycardia in three cases.
Complications
Complications are summarized in Table 5 . There were a total of three cases of complete atrioventricular block necessitating permanent pacemaker implantation. One case occurred during fast pathway ablation after failed slow pathway ablation. The second case was in a patient who had undergone attempted ablation in another institution. The third case occurred 4 weeks following apparently successful slow pathway ablation. This patient presented with presyncope and was found to have complete atrioventricular block with a ventricular escape of 40 beats . min 1 .
Characteristics of patients experiencing atrioventricular block All these patients had received five or more pulses of radiofrequency energy. In the patient undergoing fast P*=P value compared with the success group. †Note that there were a total of 379 patients: all but 10 had initially successful procedures (these went on to fast pathway ablation), 10 experienced an in-hospital recurrence and were successfully ablated.
pathway ablation, the ablation catheter was positioned very close to the His recording. In the other two cases of complete atrioventricular block the catheter was positioned in a conventional position, a significant distance from the His recording. In the second patient experiencing atrioventricular block (the patient who had undergone a unsuccessful procedure in another institution) VA conduction was only present after the administration of isoprenaline and the Wenckebach point was 360 ms, indicating a degree of damage to the atrioventricular node prior to the second procedure. However, the patient (a 48-year-old female) still had debilitating, drug-refractory, proven atrioventricular nodal reentrant tachycardia. In the two cases of atrioventricular block complicating slow pathway ablation, block occurred during the fifth and sixth pulses, respectively. The signals during the pulses were retrospectively analysed and atrioventricular block was preceded by accelerated junctional rhythm with evidence of VA block. The incidence of complete atrioventricular block following de novo slow pathway ablation was therefore 0·3% in this series. There were no cases of immediate atrioventricular block in patients undergoing a first slow pathway ablation. There were an additional six cases of transient (less than 1 h following the procedure) heart block (complete in three cases and second degree in three cases). There were three cases of permanent right bundle branch block. There was one case of cardiac perforation necessitating pericardial drainage. This occurred approximately 2 h following a successful and apparently uneventful procedure. There was an additional case of an asymptomatic but significant pericardial effusion. Significant access site haematoma formation (necessitating blood transfusion) was documented in one case. There was one retroperitoneal haematoma and one femoral vein thrombosis. There were two arteriovenous fistulae both of which were repaired surgically. There were therefore a total of five (1·3%) access site complications.
Fluoroscopy time
The mean total fluoroscopy time (diagnostic electrophysiological study plus ablation) was 27·3 (SD 38) min.
In the initial 100 cases the mean fluoroscopy time was 43 min and in the subsequent 279 cases the mean fluoroscopy time was 15 min (P<0·005).
Radiofrequency energy delivery
The mean number of pulses delivered was 3·2 (SD 3·2). In all cases energy was delivered for 60 s unless the catheter displaced or temperature was inadequate.
Follow-up
The mean follow-up was 20·6 months (SD 10·8). Ten patients had a documented recurrence of atrioventricular nodal reentrant tachycardia prior to discharge from hospital. All of these patients had a subsequent second successful procedure. There were therefore a total of 389 'successful procedures'. A total of 26 patients (6·9%) had a documented recurrence during the follow-up period. All of these patients underwent successful ablation on a subsequent occasion. The clinical characteristics of patients with either primary failure or documented recurrence are shown in Table 4 . Of the variables examined only age, number of pulses and fluoroscopy time were found to be positively associated with either primary failure or recurrence of atrioventricular nodal reentrant tachycardia. Slow pathway modification was not associated with an increased risk of recurrence. An additional 56 (14·8%) of the patients described recurrent symptoms. Of these, 21 were convinced that their symptoms were the same as prior to the procedure and 35 felt that their symptoms were different and less debilitating than prior to the procedure. Atrioventricular nodal reentrant tachycardia was not documented in any of these patients. Sixty-two patients complained of occasional palpitations (occurring less than once per week). Forty-three patients (113%) were still taking antiarrhythmic medication. These results are summarized in Table 6 .
Slow pathway ablation vs modification
The presence of one or more atrial echo beats and/or an A-H jump was documented in 190 patients in whom atrioventricular nodal reentrant tachycardia had 
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been rendered non-inducible. Thus, slow pathway modification was achieved in 50·1% of cases.
Discussion
The technique of targeting the slow pathway as a treatment for atrioventricular nodal reentrant tachycardia has been described previously. To our knowledge, however, this is the largest published series with longterm follow up. In their large, multicentre prospective trial, Calkins et al. [17] have reported results following ablation of atrioventricular nodal reentrant tachycardia in 373 patients. However, this study also deals with patients undergoing ablation of the atrioventricular junction and accessory pathways. The data is much less detailed and follow-up less complete than that presented here.
Initial and long-term success rates
On an intention-to-treat basis, the slow pathway was targeted in 379 patients. However, of these 10 subsequently went on to fast pathway ablation because slow pathway ablation was unsuccessful. The technique of targeting the slow pathway was introduced in this unit in early 1994. The cases of failed slow pathway ablation followed by fast pathway ablation are almost entirely confined to the period January to June 1994, indicating a learning curve effect. One of these cases was associated with permanent atrioventricular block necessitating pacemaker implantation. Fast pathway ablation is associated with a high incidence of complications and should no longer be necessary. This is in agreement with the observations of Morady [18] who noted that fast pathway ablation was necessary in only three of 450 patients who underwent slow pathway ablation. In our series 379 patients were treated; there were two cases of immediate atrioventricular block and 10 in hospital recurrences, giving an overall, initial success rate of 97% at the first attempt.
Incidence of complications
The overall incidence of major complications (atrioventricular block, tamponade and serious access site complications) was approximately 2%. The incidence of permanent atrioventricular block was 0·8%. However, one of these patients had undergone a previous attempt at slow pathway ablation in another unit and a second occurred during fast pathway ablation. There was only one case of atrioventricular block occurring in a patient undergoing a first slow pathway ablation in this unit and, interestingly, this occurred some weeks following the procedure. We have carefully analysed these patients and found that, in patients undergoing slow pathway ablation, atrioventricular block was associated with prolonged energy delivery (in excess of five pulses) and was heralded by evidence of VA block during accelerated junctional rhythm. This underlines the importance of careful examination of the signals during energy delivery preferably by an experienced second operator. However the incidence of atrioventricular block reported in this series compares favourably with other studies where the incidence varied between 1·3% and 8% [5] [6] [7] 10, 13, 15, 17, 19, 20] . The data also compares favourably with the incidence of atrioventricular block following fast pathway ablation. Kottkamp et al. [16] did not observe this complication in their series of patients undergoing fast pathway ablation. However, the technique used in this series required a somewhat complex stepwise approach and necessitated energy titration. In the present series, the low incidence of atrioventricular block was achieved with a mean of 1·7 pulses and a mean fluoroscopy time of 15 min (in the last 279 cases), implying that the technique was relatively simple and should be widely applicable. A serious concern surrounding techniques involving atrioventricular nodal modification is that, although the initial complication rate may be low, patients may require permanent pacemaker implantation at a later date. This is not borne out by this series. There was only one case of atrioventricular block occurring 4 weeks after the procedure. No other patients required permanent pacemaker implantation during the follow-up. Longer follow-up will be required before this concern can be completely eliminated.
Slow pathway ablation vs modification
Single atrioventricular nodal reentrant beats and/or an A-H jump were present after the procedure in 50·1% patients. This group was said to have undergone slow pathway modification. There is still some debate about whether this residual slow pathway conduction is association with a higher recurrence rate [19] [20] [21] . Three previous studies have reported a higher recurrence rate in patients with residual slow pathway conduction, but four additional studies, including those of Jackman et al. [6] and Haissaguerre et al. [8] , have failed to establish a higher recurrence rate in this group. Conversely, maintenance of dual atrioventricular nodal physiology may be associated with a lower incidence of late heart block. In this series there was no significant difference in the incidence of late recurrence in those who had undergone slow pathway ablation compared with those patients who had undergone new pathway modification. The only case of late atrioventricular block occurred in a patient who had undergone slow pathway ablation. Longer follow-up will be required before any specific conclusions can be drawn about the long-term outcomes in the two groups. However, this study does concur with previous observations that slow pathway modification is as effective as slow pathway ablation.
Follow-up
Accurate follow-up data is available in the vast majority of patients (96%). Follow-up was by questionnaire and not by outpatient interview. Clearly, it seems improbable that patients would be unaware of recurrence. Tachycardias were documented in 6·9% of patients. However, it must be stated that it is often difficult to document atrioventricular nodal reentrant tachycardia by Holter monitoring and that therefore this is likely to be an under-estimate. The 'clinical' recurrence (all those who reported identical or similar symptoms plus those with documented recurrence) was 12·4%. The only clinical characteristics positively associated with recurrence were age, number of pulses and fluoroscopy time. The latter two features can be explained by assuming that, in these patients, the slow pathway area proved more difficult to map or inadequate temperature had led to failure to destroy slow pathway tissue. It is not entirely clear why older patients should have a higher recurrence rate. It is possible that the elderly are more likely to have distorted cardiac anatomy, rendering mapping more difficult.
Patient perception
Of the 96% of patients who responded to the questionnaire, 83·6% felt that the procedure had improved their quality of life and that it had been a success. Only 11·3% were still taking antiarrhythmic medication. It is of interest that, of the 62 patients who did not feel that the procedure had been a success, only 19 (30·6%) had a documented recurrence of atrioventricular nodal reentrant tachycardia but an additional 21 (33·9%) patients complained of palpitations occurring less than once per week. In most cases where these palpitations were documented the symptoms appeared to correlate with atrial or ventricular ectopic beats.
Clearly, this data is highly subjective. It is not known if ectopic beats occur more frequently in patients who have undergone this procedure than in the general population. This would seem unlikely. However, the results do indicate the need for physicians to warn patients that, although atrioventricular nodal reentrant tachycardia may be eliminated as a clinical problem, they may still be aware of ectopic beats which may manifest as occasional palpitations.
Study limitations
This is a non-randomized retrospective series. Although it appears that slow pathway modification is as effective as ablation, it is clearly possible that some selection bias has been inadvertently introduced. Similarly, although this series gave an equal success rate and lower complication rate than previous series in which the fast pathway was ablated, it is possible that the patients in this series had different characteristics to those in other series. Only a prospective, randomized study would properly address these issues. Only a small number of patients had a documented recurrence following the procedure. Due to technical differences associated with proving recurrence, it seems likely that the true recurrence rate is closer to 15%.
Conclusions
Targeting the slow pathway is an effective form of treatment for patients with drug-refractory atrioventricular nodal reentrant tachycardia. In this series, the technique was associated with a long-term success rate of approximately 85% and an incidence of atrioventricular block of less than 1%. Slow pathway modification was as effective as slow pathway ablation. Number of pulses delivered, fluoroscopy time and age were the only characteristics which correlated with recurrence.
